07b742a17b5060ab…

{
  "id": "NCT00130429",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to assess the effect of PYM50028 administered once daily for up to 12 weeks on the memory and other faculties of subjects with dementia due to Alzheimer's disease.",
    "completionDate": "2005-09",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 250,
    "enrollmentType": null,
    "nctId": "NCT00130429",
    "phase": "PHASE2",
    "sponsorId": "phytopharm",
    "startDate": "2004-01",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Phase II Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Effect on Cognition and Pharmacokinetic Profile of PYM50028 in Subjects With Mild Dementia of the Alzheimer's Type",
    "url": "https://clinicaltrials.gov/study/NCT00130429"
  }
}